{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:40:50Z","timestamp":1791726050371,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006247","name":"Anhui University of Science and Technology","doi-asserted-by":"publisher","award":["2023cx2157"],"award-info":[{"award-number":["2023cx2157"]}],"id":[{"id":"10.13039\/501100006247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.tube.2024.102480","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:00:23Z","timestamp":1706014823000},"page":"102480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9969-7644","authenticated-orcid":false,"given":"Zian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-280X","authenticated-orcid":false,"given":"Lifa","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LingYun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangsen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2024.102480_bib1","series-title":"Global tuberculosis report 2020","year":"2020"},{"key":"10.1016\/j.tube.2024.102480_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","article-title":"WHO global progress report on tuberculosis elimination","volume":"8","author":"Harding","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2024.102480_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/d41586-021-02469-8","article-title":"How COVID is derailing the fight against HIV, TB and malaria","volume":"597","author":"Roberts","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tube.2024.102480_bib4","year":"2022"},{"key":"10.1016\/j.tube.2024.102480_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: a journey from BCG to present","volume":"252","author":"Fatima","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.tube.2024.102480_bib6","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","article-title":"Tuberculosis vaccines: beyond bacille Calmette-Guerin","volume":"366","author":"McShane","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.tube.2024.102480_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/trstmh\/trw016","article-title":"TB vaccine development and the End TB Strategy: importance and current status","volume":"110","author":"Fletcher","year":"2016","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tube.2024.102480_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tibtech.2018.10.004","article-title":"Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development","volume":"37","author":"Tom","year":"2019","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.tube.2024.102480_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940047","article-title":"Vaccine adjuvants to engage the cross-presentation pathway","volume":"13","author":"Lee","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2024.102480_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"issue":"41","key":"10.1016\/j.tube.2024.102480_bib11","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.vaccine.2013.07.032","article-title":"Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens","volume":"31","author":"Derrick","year":"2013","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.tube.2024.102480_bib12","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.tube.2024.102480_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247990","article-title":"Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model","volume":"16","author":"Baldwin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102480_bib14","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1080\/21645515.2021.1885280","article-title":"A review of the BCG vaccine and other approaches toward tuberculosis eradication","volume":"17","author":"Cho","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tube.2024.102480_bib15","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.vaccine.2013.07.032","article-title":"Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens","volume":"31","author":"Derrick","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2024.102480_bib16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12275-015-5333-8","article-title":"The Mycobacterium tuberculosis relBE toxin:antitoxin genes are stress-responsive modules that regulate growth through translation inhibition","volume":"53","author":"Korch","year":"2015","journal-title":"J Microbiol"},{"key":"10.1016\/j.tube.2024.102480_bib17","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1128\/JB.01318-08","article-title":"Three Mycobacterium tuberculosis Rel toxin-antitoxin modules inhibit mycobacterial growth and are expressed in infected human macrophages","volume":"191","author":"Korch","year":"2009","journal-title":"J Bacteriol"},{"key":"10.1016\/j.tube.2024.102480_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1107\/S2053230X1401317X","article-title":"The RpfC (Rv1884) atomic structure shows high structural conservation within the resuscitation-promoting factor catalytic domain","volume":"70","author":"Chauviac","year":"2014","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"10.1016\/j.tube.2024.102480_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fcimb.2017.00226","article-title":"Immunogenicity and protective efficacy of a fusion protein tuberculosis vaccine combining five esx family proteins","volume":"7","author":"Xiang","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.tube.2024.102480_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1348-0421.2011.00376.x","article-title":"Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein","volume":"55","author":"Deng","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.tube.2024.102480_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7906724","article-title":"Mouse IgG2a antibodies specific for the commensal Streptococcus mitis show stronger cross-reactivity with Streptococcus pneumoniae than IgG1 antibodies","volume":"2019","author":"Shekhar","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.tube.2024.102480_bib22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3389\/fmicb.2017.00623","article-title":"Modulation of macrophage responses by CMX, a fusion protein composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis","volume":"8","author":"da Costa","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102480_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.tube.2024.102480_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","article-title":"Developments in vaccine adjuvants","volume":"2412","author":"Firdaus","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.tube.2024.102480_bib25","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2024.102480_bib26","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tube.2024.102480_bib27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/IAI.69.2.810-815.2001","article-title":"Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice","volume":"69","author":"Yamagami","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2024.102480_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.100942","article-title":"Synthesis of protein conjugates adsorbed on cationic liposomes surface","volume":"7","author":"Chatzikleanthous","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.tube.2024.102480_bib29","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2024.102480_bib30","first-page":"46","article-title":"Design and construction of a cloning vector containing the hspX gene of Mycobacterium tuberculosis","volume":"5","author":"Yaghoubi","year":"2016","journal-title":"Rep Biochem Mol Biol"},{"key":"10.1016\/j.tube.2024.102480_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.rvsc.2021.04.014","article-title":"The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis","volume":"136","author":"Blanco","year":"2021","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.tube.2024.102480_bib32","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.1102696","article-title":"The importance of adjuvant formulation in the development of a tuberculosis vaccine","volume":"188","author":"Baldwin","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2024.102480_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tube.2012.10.011","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02 in PPD positive adults: a randomized controlled phase I\/II study","volume":"93","author":"Spertini","year":"2013","journal-title":"Tuberculosis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:46:57Z","timestamp":1761468417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979224000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"alternative-id":["S1472979224000064"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2024.102480","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2024.102480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102480"}}